title: Opposite effects of cell growth factors and cicletanine sulfate on the sodium-independent [Cl-/HCO3-] exchange in cultured vascular smooth muscle.
abstract: Cicletanine sulfate was tested on bicarbonate-dependent pHi changes in cultured vascular smooth muscle (A10 line). Cicletanine sulfate exhibited double reactivity with regard to the cell alkalinization induced by bicarbonate uptake. The analysis of 11 concentration-response curves revealed a high reactivity component (IC50 approximately 3.5 x 10(-8) mol/L) and a weak reactivity component (IC50 approximately 4 x 10(-4) ml/L). Regarding the cell acidification induced by bicarbonate extrusion, cicletanine sulfate exhibited a single high reactivity component (IC50 = 5.9 +/- 2.9 x 10(-7) mol/l; mean +/- SD, n = 7). The high and weak reactivity sites were both sensitive to DIDS. Analysis of the data strongly suggested that the highly reactive site corresponds to a sodium-independent (Cl-/HCO3-] exchanger, which catalyzes net bicarbonate efflux, and the weak-reactivity site corresponds to the inwardly directed sodium-dependent [Cl-/HCO3-] exchanger. Three cell growth factors--epidermal growth factor, arginine-vasopressin, and insulin--were able to stimulate the sodium-independent [Cl-/HCO3-] exchanger in A10 cells. Finally, cicletanine sulfate (30 mumol/L) partially inhibited serum-dependent A10 cell growth. In conclusion, cicletanine sulfate and cell growth factors exert opposite effects (inhibition and stimulation, respectively) on the sodium-independent [Cl-/HCO3-] exchanger in cultured vascular smooth muscle. The effect of cicletanine sulfate on the sodium-independent [Cl-/HCO3-] exchanger may account for the ability of cicletanine to favorably alter vascular pathology in spontaneously hypertensive rat (SHR) models.
authors.affiliation: INSERM U2/CNRS UA 130251, Faculté de Médecine, Créteil and IPSEN, Paris, France.
authors.forename: K
authors.initials: K
authors.lastname: Fanous
authors.forename: C
authors.initials: C
authors.lastname: Nazaret
authors.forename: N
authors.initials: N
authors.lastname: Senn
authors.forename: E
authors.initials: E
authors.lastname: Decoopman-Morin
authors.forename: M
authors.initials: M
authors.lastname: Allard
authors.forename: R P
authors.initials: RP
authors.lastname: Garay
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D017920:Antiporters / Q000378:metabolism*; D001013:Aorta, Thoracic / Q000187:drug effects / Q000378:metabolism; D001127:Arginine Vasopressin / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D027963:Chloride-Bicarbonate Antiporters; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006133:Growth Substances / Q000494:pharmacology*; D006859:Hydrogen / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism*; D011247:Pregnancy; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D012964:Sodium / Q000378:metabolism / Q000502:physiology
chemical_list: D000959:Antihypertensive Agents; D017920:Antiporters; D027963:Chloride-Bicarbonate Antiporters; D006133:Growth Substances; D011725:Pyridines; D001127:Arginine Vasopressin; D006859:Hydrogen; D012964:Sodium; C038068:cicletanine